Kimberly-Clark Health Care created the HAI WATCHDOG Awards program to recognize the efforts of dedicated healthcare professionals helping to prevent HAIs in their healthcare facilities and to allow healthcare providers to share best practices for infection prevention. The deadline to submit a program is December 15, 2010.
Kimberly-Clark Health Care will award four programs with an educational grant, a commemorative plaque and healthcare industry and local community recognition through press releases and features on the HAI WATCHDOG website and in Kimberly-Clark Infection Watch e-newsletters.
Programs with measureable results will be judged by a panel of infection prevention healthcare professionals, while the education and awareness programs with non-measurable results will be judged by online public voting of fellow healthcare professionals through Dec. 31, 2010.
The deadline to participate in the Awards program through online entry is December 15, 2010 for programs conducted between Oct. 1, 2009 and Dec. 15, 2010.
To participate or learn more, visit the HAI WATCHDOG Awards website at http://haiwatchdog.com/pg/hai_contest_pages/read/contest_about
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.